论文部分内容阅读
目的 评价通心络胶囊应用在老年冠心病患者治疗当中的效果?方法 对2018 年4 月至2019 年10 月来我院治疗的70 例老年冠心病患者，以随机分组方法分为观察组与对照组，每组35 例?两组分别以通心络胶囊和常规治疗方法治疗，比较效果?结果 ①治疗后观察组(33 例，占94.29%)的总有效率明显比对照组(24 例，占68.57%)更高，有统计学差异性(P 0.“,”Objective To evaluate the effect of Tongxinluo capsule in the treatment of elderly patients with coronary heart disease. Methods A total of 70 elderly patients with coronary heart disease who came to our hospital for treatment from April 2018 to October 2019 were randomly divided into observation group and control group， with 35 cases in each. The two groups were treated with Tongxinluo Capsules and conventional treatment methods respectively， and the effects were compared. Results (1) After treatment， the total effective rate of the observation group (33 cases， accounting for 94.29%) was significantly higher than that of the control group (24 cases， accounting for 68.57%)， and there was a statistical difference (P0.05). (3) After treatment， the improvement indicators of inflammatory factors in the observation group were significantly better than those in the control group， with statistical differences (P <0.05). Conclusion The use of Tongxinluo Capsule to treat elderly patients with coronary heart disease can improve the overall efficiency of the patient\'s treatment， and is safer， does not cause serious side effects of medication， and can fully exert its anti-inflammatory effect. It is worth recommending.